Failure Of Eli Lilly Insulin Deal Won't End Patients' Litigation
The collapse of a massive deal to settle claims Eli Lilly illegally inflated insulin prices may not alter the trajectory of the underlying litigation, as patients are already pressing ahead with...To view the full article, register now.
Already a subscriber? Click here to view full article